Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-109.3M
Cash
346.2M
Avg Qtr Burn
-16.62M
Short % of Float
11.14%
Insider Ownership
10.78%
Institutional Own.
85.04%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
KYV-101 Details Lupus nephritis | Phase 1 Update |